Exact Sciences (EXAS) PT Bumped at Jefferies Post Q2

July 23, 2014 8:55 AM

Jefferies analyst Brandon Couillard raised his price target but lowered estimates on Buy-rated Exact Sciences (NASDAQ: EXAS) following Q2 results.Couillard ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found